KM-301

N/A

Report date: 2025/01/26 18:32:00

NME

Base Information

Drug NameKM-301

Drug Alias NameEZH2 Inhibitor (Kainos Medicine)KM-301

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHistone-lysine N-methyltransferase EZH2 degraders

TargetsHistone-lysine N-methyltransferase EZH2

Therapy Area/IndicationsLymphoma, Non-Hodgkin

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKainos Medicine Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsLymphoma, Non-Hodgkin

Inactive IndicationsN/A

ATC CodeN/A